pioglitazone has been researched along with Pancytopenia in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karakurt, F | 1 |
| Kargili, A | 1 |
| Kasapoglu, B | 1 |
| Favre, G | 1 |
| Valnet-Rabier, MB | 1 |
| Brousse, A | 1 |
| Lepiller, Q | 1 |
| Kantelip, JP | 1 |
2 other studies available for pioglitazone and Pancytopenia
| Article | Year |
|---|---|
Pioglitazone induced reversible pancytopenia.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Male; Middle Aged; Pancytopenia; Pioglitazon | 2010 |
Pioglitazone-induced progressive pancytopenia.
Topics: Diabetes Mellitus, Type 2; Disease Progression; Humans; Hypoglycemic Agents; Male; Middle Aged; Panc | 2011 |